A theme involving the development of a diagnostic technology that visualises tumour location and extent and boron-drug uptake using 18F-FBPA-PET, enabling prior assessment of BNCT eligibility and treatment efficacy. It concerns the commercialisation of an imaging diagnostic technology that supports treatment selection, rather than BNCT treatment itself.